Schultze-Mosgau A

No ORCID on file · 6 papers in corpus
2026
Human reproduction open ·doi:10.1093/hropen/hoag018

Study questionAre previously proposed vaginal microbial community state types (CSTs) valid predictors of IVF success, or do alternative microbial signatures provide stronger associations?Summary answerPreviously proposed CSTs as predictors …

other 2013
Archives of gynecology and obstetrics ·doi:10.1007/s00404-013-2794-z

PURPOSE: In the GnRH-antagonist protocol, ovarian stimulation with gonadotropins typically commences on cycle day 2 or 3. Initiation of ovarian stimulation with a spontaneously occurring menstruation, however, poses significant organization…

review 2006
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.7.15.2155

The use of cetrorelix within ovarian-stimulation protocols demonstrates several advantages compared with gonadotropin-releasing hormone (GnRH) agonist-containing protocols, which include, for example, significantly less time for analogue tr…

article 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.05.043

ObjectiveTo compare the amount of regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 (MCP-1) in follicular fluid (FF) of patients with and without endometriosis and to determine their…

review 2005
Expert opinion on investigational drugs ·doi:10.1517/13543784.14.9.1085

Gonadotropin-releasing hormone (GnRH) stimulates the pituitary secretion of both luteinising hormone (LH) and follicle-stimulating hormone (FSH), and thus controls the hormonal and reproductive functions of the gonads. The blockade of the e…

other 1998
Human Reproduction Update ·doi:10.1093/humupd/4.5.719

During the past decade, macrophage-derived substances such as prostanoids, cytokines, growth factors and angiogenic factors have been detected in the peritoneal fluid of women with endometriosis. In particular, growth-promoting and angiogen…